PavaniChalasaniMDMPH

Breast Cancer

Director, Division of Hematology-Oncology Medical Director, Inpatient Oncology Services Co-Lead, Clinical and Translational Oncology Program George Washington Cancer Center George Washington University

Request Appointment

Overview of Dr. Chalasani

Dr. Pavani Chalasani is an oncologist in Washington, DC and is affiliated with multiple hospitals in the area, including George Washington University Hospital and Banner - University Medical Center Tucson. She received her medical degree from Gandhi Medical College and has been in practice 15 years. Dr. Chalasani accepts several types of health insurance, listed below. She is one of 41 doctors at Banner - University Medical Center Tucson and one of 38 doctors at George Washington University Hospital who specialize in Oncology. She has more than 50 publications and over 500 citings.

Office
2150 Pennsylvania Ave NW
Washington, DC 20037
Book by Phone+1(954) 914-7021

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2006 - 2009
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 2004 - 2005
Gandhi Medical CollegeClass of 2002

Certifications & Licensure

AZ State Medical License 2009 - 2024
DC State Medical License 2023 - 2024
IL State Medical License 2004 - 2007
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer Start of enrollment: 2014 Jan 08
Completed
Phase 2
Estradiol Levels in Patients Treated With Estring Start of enrollment: 2013 Aug 09
Completed
Phase 2
Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN) Start of enrollment: 2017 Aug 11
Completed
Not Applicable
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer Start of enrollment: 2018 Dec 06
Completed
Phase 2
Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets Start of enrollment: 2018 Dec 19
Completed
Early Phase 1
Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome Start of enrollment: 2018 Feb 28
Completed
Not Applicable
Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors Start of enrollment: 2019 Apr 19
Active, not recruiting
Early Phase 1
Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women Start of enrollment: 2022 Aug 30
Withdrawn
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia Start of enrollment: 2020 Apr 27
Completed
Early Phase 1
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) Start of enrollment: 2018 Jun 27
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery Start of enrollment: 2020 Feb 20
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Novel Thermal Imaging Technique for Breast Screening Start of enrollment: 2022 Nov 15
Suspended
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

42 citations
Differential Chemotherapeutic Sensitivity for Breast Tumors With “BRCAness”: A Review
Pavani Chalasani, Robert B. Livingston
The Oncologist. 2013-08-01
2 citations
Diffuse tensor imaging of lower extremities: a novel MR imaging technique for chemotherapy-induced peripheral neuropathy
Pavani Chalasani, Mihra S. Taljanovic, Jenn Segar, Kiah J. Farr, Hninyee Win
Breast Cancer Research and Treatment. 2020-08-28
50 citations
Randomized controlled trial of supportive care interventions to manage psychological distress and symptoms in Latinas with breast cancer and their informal caregivers.
Terry A. Badger, Chris Segrin, Alla Sikorskii, Alice Pasvogel, Karen L. Weihs
Psychology & Health. 2020-01-02

Press Mentions

New Diagnostic Tool Helps Identify When Antifibrotic Therapy in Breast Cancer Makes SenseNovember 4th, 2024
Precision Oncology: Role of MeCo Score in Personalized Breast Cancer TherapyOctober 23rd, 2024
Clinical Study Confirms Tissue Stiffening in Breast Cancer Can Drive MetastasisOctober 22nd, 2024
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Health Net Arizona PPO/POS
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust Preferred Provider Plan - Trust Pref
Please verify your coverage with the provider's office directly when scheduling an appointment